Search Results - "Bepperling, F"

Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution by Ickx, B.E., Bepperling, F., Melot, C., Schulman, C., Van der Linden, P.J.

“…The volume expansion effect of a recently introduced hydroxyethyl starch, HES 130/0.4, was compared with the commonly used HES 200/0.5 after rapid infusion of…”
Get full text

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients by Ertmer, C, Wulf, H, Van Aken, H, Friederich, P, Mahl, C, Bepperling, F, Westphal, M, Gogarten, W

“…Hydroxyethyl starch (HES) solutions are frequently used for perioperative volume replacement. Whereas older HES specimen tended to accumulate in the plasma and…”
Get more information

A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery by GALLANDAT HUET, R. C. G, SIEMONS, A. W, BAUS, D, VAN ROOYEN-BUTIJN, W. T, HAAGENAARS, J. A. M, VAN OEVEREN, W, BEPPERLING, F

Get full text

The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment by JUNGHEINRICH, Cornelius, SCHARPF, Roland, WARGENAU, Manfred, BEPPERLING, Frank, BARON, Jean-Francois

“…Hydroxyethyl starches (HES) are almost exclusively excreted glomerularly, in part after hydrolysis by amylase. HES 130/0.4 (Voluven; Fresenius Kabi Deutschland…”
Get full text

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients by Ertmer, C, Van Aken, H, Wulf, H, Friederich, P, Mahl, C, Bepperling, F, Westphal, M, Gogarten, W

Get full text

A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery by Gallandat Huet, R C, Siemons, A W, Baus, D, van Rooyen-Butijn, W T, Haagenaars, J A, van Oeveren, W, Bepperling, F

“…To compare the new hydroxyethyl starch HES 130/0.4 (Voluven) and the standard HES 200/0.5 (pentastarch) regarding effectiveness for plasma volume substitution…”
Get full text

Effect of 5 alpha-dihydrocorticoids on enzymes of gluconeogenesis in rat liver by Golf, S W, Bepperling, F, Graef, V

“…5 alpha-Dihydrocortisol (11 beta, 17, 21-trihydroxy-5 alpha-pregnane-3,20-dione), 5 alpha-dihydrocorticosterone (11 beta, 21-dihydroxy-5…”
Get more information

Volume substitution therapy with HES 130/0.4 (Voluven®) versus HES 450/0.7 (hetastarch) during major orthopedic surgery by Gandhi, S, Warltier, D, Weiskopf, R, Bepperling, F, Baus, D, Jungheinrich, C

Get full text

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (Cmax)remain unaffected by Jungheinrich, C, Scharpf, R, Wargenau, M, Bepperling, F

Get full text

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats by Bepperling, F, Opitz, J, Leuschner, J

Get full text

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers by Waitzinger, J, Bepperling, F, Pabst, G, Opitz, J, Müller, M, François Baron, J

“…To investigate the pharmacokinetic profile and tolerability of a single-dose infusion of the new hydroxyethyl starch (HES) specification, HES (130/0.4), 6% and…”
Get full text

Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study by Grauer, MT, Baus, D, Woessner, R, Bepperling, F, Kahles, T, Georgi, S, Bianchi, O, Treib, J

Get full text

Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study by Woessner, Ralph, Grauer, Markus T, Dieterich, Hans-Jürgen, Bepperling, Frank, Baus, Daniela, Kahles, Timo, Georgi, Sven, Bianchi, Oliver, Morgenthaler, Martin, Treib, Johannes

“…This study was performed to investigate the clinical effects of a 4-day volume therapy with a newly developed, 6% hydroxyethyl starch (HES) 130/0.4 versus…”
Get more information

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers by Bepperling, F, Opitz, J, Waitzinger, J, Pabst, G, Müller, M, Baron, JF

Get full text

Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers by Waitzinger, Josef, Bepperling, Frank, Pabst, G??nther, Opitz, Jens, Fackelmayer, Andrea, Boldt, Joachim

Get full text